Evidence map›Paper›PMID 32451486›Full record

SynthesisNature neuroscience2020

Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits.

Hang Zhou, Julia M Sealock, Sandra Sanchez-Roige, Toni-Kim Clarke, Daniel F Levey, Zhongshan Cheng, Boyang Li, Renato Polimanti, Rachel L Kember, Rachel Vickers Smith and 16 more

Registry-linked trialAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03170362 (PRIME Care), which is not on this map. Cited by 253 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
253citing papers in PubMed, 16 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03170362 nacompletednot on this map

PRIME Care (PRecision Medicine In MEntal Health Care)

TypeinterventionalSponsorVA Office of Research and DevelopmentRan2017 to 2022Enrolled1,944ConditionsMajor DepressionArmsPharmacogenetic Test
3 · Its place in the literature

Who cites it

253 citing papers in PubMed, 16 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The genetics of cannabis lifetime use.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Genome-wide meta-analysis of alcohol use disorder in East Asians.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Article
  18. Genetic overlap between treatment-resistant schizophrenia and smoking initiation.The international journal of neuropsychopharmacology · 2026
    Article
  19. Article
  20. Article

193 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Hang ZhouDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-7694-6391
Julia M SealockVanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.
Sandra Sanchez-RoigeDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-6137-5699
Toni-Kim ClarkeDivision of Psychiatry, University of Edinburgh, Edinburgh, UK.
Daniel F LeveyDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-8431-9569
Zhongshan ChengDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Boyang LiDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-2808-9986
Renato PolimantiDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Rachel L KemberDepartment of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Rachel Vickers SmithUniversity of Louisville School of Nursing, Louisville, KY, USA.ORCID http://orcid.org/0000-0002-7224-8916
Johan H ThygesenDivision of Psychiatry, University College London, London, UK.
Marsha Y MorganUCL Institute for Liver & Digestive Health, Division of Medicine, Royal Free Campus, University College London, London, UK.ORCID http://orcid.org/0000-0001-6134-1026
Stephen R AtkinsonDepartment of Metabolism Digestion & Reproduction, Imperial College London, London, UK.
Mark R ThurszDepartment of Metabolism Digestion & Reproduction, Imperial College London, London, UK.
Mette NyegaardDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-2967-6624
Manuel MattheisenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Anders D BørglumDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Emma C JohnsonDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-0394-777X
Amy C JusticeVeterans Affairs Connecticut Healthcare System, West Haven, CT, USA.ORCID http://orcid.org/0000-0003-0139-5502
Abraham A PalmerDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3634-0747
Andrew McQuillinDivision of Psychiatry, University College London, London, UK.ORCID http://orcid.org/0000-0003-1567-2240
Lea K DavisVanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-5143-2282
Howard J EdenbergDepartment of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0003-0344-9690
Arpana AgrawalDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-0313-793X
Henry R KranzlerCrescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-1018-0450
Joel GelernterDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA. joel.gelernter@yale.edu.ORCID http://orcid.org/0000-0002-4067-1859

Funding

Subject CollectionU10AA008401 · NIAAA · SUNY DOWNSTATE MEDICAL CENTER · PI Yunlong Liu · 1989 to 2026
$162.7M
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Translational Technologies CoreP50AA012870 · NIAAA · YALE UNIVERSITY · PI John H. Krystal · 2001 to 2026
$43.7M
Training Program on Genetic Variation and Human PhenotypesT32GM080178 · NIGMS · VANDERBILT UNIVERSITY · PI COX, NANCY J, SAMUELS, DAVID C · 2007 to 2021
$3.1M
7/7 Psychiatric Genomics Consortium: Finding actionable variationU01MH109532 · NIMH · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA, EDENBERG, HOWARD J · 2016 to 2020
$3.1M
5/7 Psychiatric Genomics Consortium: Finding actionable variationU01MH109514 · NIMH · CARDIFF UNIVERSITY · PI O'DONOVAN, MICHAEL · 2016 to 2020
$2.9M
Modular Automated -80C Sample Storage SystemS10OD025092 · OD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GOLDENRING, JAMES RICHARD · 2019 to 2019
$2.0M
DELINEATING THE ROLE OF GENETIC INFLUENCES ON CANNABIS INVOLVEMENTK02DA032573 · NIDA · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA · 2012 to 2021
$1.1M
Genetic Vulnerability for Sustained Multi-Substance Use in MVPI01BX003341 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI FEDERMAN, DANIEL, JUSTICE, AMY CAROLINE · 2017 to 2017
–
Genomics of PTSD and Related TraitsI01CX001849 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI GELERNTER, JOEL, STEIN, MURRAY B. · 2019 to 2022
–
BLRD VA I01 BX003341BLRD VA I01 BX004820BLRD VA I01 BX006482CSRD VA I01 CX001849Department of HealthMedical Research Council G0500791Medical Research Council G0701007Medical Research Council G1000708Medical Research Council G9623693NMedical Research Council MR/M003132/1NCATS NIH HHS UL1 TR001863NIAAA NIH HHS P50 AA012870NIAAA NIH HHS U10 AA008401NIA NIH HHS U24 AG021886NIDA NIH HHS K02 DA032573NIGMS NIH HHS T32 GM080178NIH HHS S10 OD025092NIMH NIH HHS U01 MH109514NIMH NIH HHS U01 MH109532Wellcome Trust
6 · The paper itself

Abstract

Problematic alcohol use (PAU) is a leading cause of death and disability worldwide. Although genome-wide association studies have identified PAU risk genes, the genetic architecture of this trait is not fully understood. We conducted a proxy-phenotype meta-analysis of PAU, combining alcohol use disorder and problematic drinking, in 435,563 European-ancestry individuals. We identified 29 independent risk variants, 19 of them novel. PAU was genetically correlated with 138 phenotypes, including substance use and psychiatric traits. Phenome-wide polygenic risk score analysis in an independent biobank sample (BioVU, n = 67,589) confirmed the genetic correlations between PAU and substance use and psychiatric disorders. Genetic heritability of PAU was enriched in brain and in conserved and regulatory genomic regions. Mendelian randomization suggested causal effects on liability to PAU of substance use, psychiatric status, risk-taking behavior and cognitive performance. In summary, this large PAU meta-analysis identified novel risk loci and revealed genetic relationships with numerous other traits.

Indexed as

Genetic Predisposition to DiseaseAlcohol DrinkingAlcoholismDatasets as TopicFemaleGenome-Wide Association StudyHumansMaleMultifactorial Inheritance

Identifiers

PMID32451486
PMCPMC7485556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.